Provided by Tiger Fintech (Singapore) Pte. Ltd.

Teva Pharmaceutical

13.31
-0.3400-2.49%
Post-market: 13.390.0799+0.60%18:32 EDT
Volume:12.06M
Turnover:159.78M
Market Cap:15.25B
PE:-9.18
High:13.46
Open:13.46
Low:13.04
Close:13.65
Loading ...

Teva call volume above normal and directionally bullish

TIPRANKS
·
Yesterday

Teva Pharmaceutical Industries (TEVA): Among the Top Healthcare Stocks to Buy According to Billionaire David Einhorn

Insider Monkey
·
12 Apr

Teva Pharmaceutical Industries (NYSE:TEVA) Pops As FDA Expands AJOVY'S Use For Pediatric Migraine Prevention

Simply Wall St.
·
10 Apr

Teva put volume heavy and directionally bearish

TIPRANKS
·
09 Apr

Teva Pharmaceutical Industries Limited (TEVA): A Bull Case Theory

Insider Monkey
·
08 Apr

BRIEF-Biosimilar Epysqli® (Eculizumab-Aagh) Injection Now Available In The United States

Reuters
·
07 Apr

Teva Rolls Out Lower-Cost Soliris Biosimilar in US

MT Newswires Live
·
07 Apr

Teva, Samsung Bioepis announce EPYSQLI availability in the U.S.

TIPRANKS
·
07 Apr

Teva Pharmaceutical Industries Says US FDA Accepted its sBLA Filing for AJOVY

MT Newswires Live
·
07 Apr

Teva Pharmaceutical Industries Ltd - Epysqli Available at 30% Discount to Soliris Wac

THOMSON REUTERS
·
07 Apr

Teva and Samsung Bioepis Announce Biosimilar Epysqli® (Eculizumab-Aagh) Injection NOW Available in the United States

THOMSON REUTERS
·
07 Apr

Teva and Samsung Bioepis Announce Biosimilar EPYSQLI® (eculizumab-aagh) Injection Now Available in the United States

GlobeNewswire
·
07 Apr

Teva announces FDA acceptance of sBLA for AJOVY

TIPRANKS
·
07 Apr

Top Stock Reports for Cisco, Caterpillar & CME

Zacks
·
04 Apr

Teva Pharmaceuticals : UBS Cuts Target Price to $24 From $27

THOMSON REUTERS
·
01 Apr

Teva Says Schizophrenia Trial Survey Results Show Patient Satisfaction With TEV-'749

MT Newswires Live
·
01 Apr

Teva announces presentation of survey study on TEV-‘749

TIPRANKS
·
01 Apr

Teva Pharmaceutical's Upcoming Cost-Optimization Plan May Offer Significant Benefits, UBS Says

MT Newswires Live
·
31 Mar

Piper Sandler Keeps Their Buy Rating on Teva Pharmaceutical (TEVA)

TIPRANKS
·
31 Mar

Teva Releases Q1 2025 Aide Memoire

THOMSON REUTERS
·
28 Mar